HTML clipboardTechNavio’s analysts forecast the Global Hepatitis C Drugs market to grow at a CAGR of 28 percent over the period 2011–2015. One of the key factors contributing to this market growth is the increasing prevalence of hepatitis C infection. The Global Hepatitis C Drugs market has also been witnessing the shift of treatments from multiple drug therapy to single drug therapy. However, the virus developing resistance to the drugs could pose a challenge to the growth of this market. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/global-hepatitis-c-drugs-market-2011-2015.html
 
 TechNavio’s report, the Global Hepatitis C Drugs Market 2011–2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hepatitis C Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
 
 Key vendors dominating this market space include GlaxoSmithKline plc, Merck & Co. Inc., Roche Holding Ltd., and Vertex Pharmaceuticals Ltd.
 
 Key questions answered in this report:
 What will the market size be in 2015 and at what rate will it grow?
 What key trends is this market subject to?
 What is driving this market?
 What are the challenges to market growth?
 Who are the key vendors in this market space?
 What are the opportunities and threats faced by each of these key vendors?
 What are the strengths and weaknesses of each of these key vendors?
 
 01. Executive Summary
 02. Introduction
 03. Market Coverage
 04. Market Landscape
 05. Geographical Segmentation
 06. Key Leading Countries
 07. Rate of Incidence and Prevalence
 08. Vendor Landscape
 09. Buying Criteria
 10. Market Growth Drivers
 11. Drivers and their Impact
 12. Market Challenges
 13. Impact of Drivers and Challenges
 14. Market Trends
 15. Key Vendor Analysis
 15.1 Roche Holding Ltd.
 15.2 Merck & Co. Inc.
 15.3 GlaxoSmithKline plc
 15.4 Vertex Pharmaceuticals Ltd.
 16. Other Reports in this Series
 
 List of Exhibits:
 Exhibit 1: Global Hepatitis C Drugs Market 2011–2015 (US$ billion)
 Exhibit 2: Global Hepatitis C Drugs Market Segmentation by Therapy 2011
 Exhibit 3: Global Hepatitis C Drugs Market by Geographical Segmentation 2011
 Exhibit 4: Hepatitis C Infection by Source 2011
 Exhibit 5: Global Hepatitis C Drugs Market by Vendor Segmentation 2011
 
 For more information kindly visit :
 Global Hepatitis C Drugs Market 2011-2015
 
 Or
 
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: http://twitter.com/#!/Sandhya3B
 Our Blogs: http://healthcareraj.blogspot.com/
 http://bharatbook.posterous.com/